Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

4th Biomarker Workshop at the NMI in Reutlingen: Another success

05.02.2008
The Biomarker Workshop held at the NMI in late January has become a fixed date for a growing number of proteomics researchers. With an attendance of 130, this year's workshop exceeded all previous ones. Those who were keen to find out more about the latest trends and findings were presented with a successful mix of basic and applied research information.

"The workshop has become well established and continues to present excellent speakers and new insights into proteomics," said Prof. Dr. Hugo Hämmerle, the new director of the NMI Natural and Medical Sciences Institute, at the opening of this year's Biomarker Workshop on 30th January 2008.

The experienced organisational team under the direction of Dr. Thomas Joos (NMI Reutlingen) and Dr. Jutta Bachmann (BioChipNet) once more presented an exceptional programme. Joos was pleased that all the speakers who had been invited accepted the invitation to come to Reutlingen - an indication of the excellence and the positive reputation of the workshop.

The first of the distinguished speakers to give a presentation was Dr. Oliver Steinbach, head of "Bio-Molecular Engineering" at Philips, who portrayed the latest developments in the Philips research labs in Eindhoven. Steinbach highlighted the increasing importance of molecular imaging in all areas of medicine, from research to preclinical drug development and diagnostics. The development of new and more effective technical solutions goes hand in hand with the development of a growing and more specific repertoire of targeted contrast agents that can be directed to specific parts of the body using biomarkers. Biomarkers are a key research topic at the NMI, which Steinbach cited as a major centre for proteomics.

Biomarkers are increasingly used in research and medicine

Dr. Thomas Caskey, a renowned researcher in molecular medicine (Houston, Texas, USA), gave a presentation on stem cell research. Caskey is the head of Molecular Medicine at the University of Texas and directs the Brown Foundation's Research Institute for Molecular Medicine. Caskey and his team used molecular genetic methods to differentiate embryonic stem cells into lung tissue cells (alveolar type II cells). Using specific biomarkers, Caskey's team was able to characterise the cells and identify the correct degree of differentiation.

In the third presentation, Dr. Hanno Langen (head of Proteomics at Hoffmann-La Roche in Basel, Switzerland) introduced innovative technologies in biomarker development that raise new prospects. Using the search for colon cancer markers as an example, Langen presented the time-consuming process of selecting suitable biomarker candidates. Dr. Mike Spain (Rules Based Medicine, Texas, USA) continued by portraying the use of biomarkers in simple ex-vivo methods in order to test drug candidates in whole blood cultures. Rules Based Medicine (RBM) is an international leader in the identification of biomarkers using multiplex technologies. In autumn 2007, RBM acquired EDI GmbH in Reutlingen.

Market opportunities for proteome-based technologies

Dr. Hans Berger (HB Consulting, Graz, Austria) presented a completely different perspective by elucidating the most important patents in the area of protein microarrays, their beginnings and the opportunities for new technologies. A specific class of substances, which in the USA alone has led to more than 400 patents and patent applications, are aptamers. These short single-strand nucleotides have a particular 3D structure and only bind to certain molecules. Dr. Larry Gold, CEO of SomaLogic, Boulder, USA showed how biomarkers can be identified using aptamers. Based on aptamers, SomeLogic introduced a proteomics platform with which it is possible to quantify a multitude of proteins in one approach.

NMI is the leader in the implementation of new proteomics results

Simultaneous, miniaturised approaches have boomed over the last few years, both in research as well as in industrial applications. As the NMI itself is a leader in the development of miniaturised immunoassay approaches, Dr. Thomas Joos described the enormous range of applications and new, innovative developments at the NMI. These developments include innovative methods that enable it to measure several dozen analytes in small amounts of sample, for example in 96-well format cell cultures.

Dr. Oliver Poetz, who also carries out research at the NMI in Reutlingen, completed the round of excellent presentations with a talk on "Triple X Proteomics". Working in the team of Thomas Joos, Poetz is developing peptide-specific capture antibodies (TXP antibodies) that can be used to enrich peptide groups sharing the same terminals sequence. Mass spectrometry readout allows the detection of these peptides. This approach makes it possible to overcome the currently problematic species-specificity of antibodies and generate antibodies that can be used for the detection of proteins in plants, animals and humans.

Dr. Nadja Gugeler | idw
Further information:
http://www.biochipnet.de
http://www.nmi.de/

More articles from Seminars Workshops:

nachricht Virtual Worlds: Research Trends in Mobile 3D Data Collection
30.11.2016 | Fraunhofer IPM

nachricht 4th UKP-Workshop 2017 – Save the Date!
15.09.2016 | Fraunhofer-Institut für Lasertechnik ILT

All articles from Seminars Workshops >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Breakthrough with a chain of gold atoms

In the field of nanoscience, an international team of physicists with participants from Konstanz has achieved a breakthrough in understanding heat transport

In the field of nanoscience, an international team of physicists with participants from Konstanz has achieved a breakthrough in understanding heat transport

Im Focus: DNA repair: a new letter in the cell alphabet

Results reveal how discoveries may be hidden in scientific “blind spots”

Cells need to repair damaged DNA in our genes to prevent the development of cancer and other diseases. Our cells therefore activate and send “repair-proteins”...

Im Focus: Dresdner scientists print tomorrow’s world

The Fraunhofer IWS Dresden and Technische Universität Dresden inaugurated their jointly operated Center for Additive Manufacturing Dresden (AMCD) with a festive ceremony on February 7, 2017. Scientists from various disciplines perform research on materials, additive manufacturing processes and innovative technologies, which build up components in a layer by layer process. This technology opens up new horizons for component design and combinations of functions. For example during fabrication, electrical conductors and sensors are already able to be additively manufactured into components. They provide information about stress conditions of a product during operation.

The 3D-printing technology, or additive manufacturing as it is often called, has long made the step out of scientific research laboratories into industrial...

Im Focus: Mimicking nature's cellular architectures via 3-D printing

Research offers new level of control over the structure of 3-D printed materials

Nature does amazing things with limited design materials. Grass, for example, can support its own weight, resist strong wind loads, and recover after being...

Im Focus: Three Magnetic States for Each Hole

Nanometer-scale magnetic perforated grids could create new possibilities for computing. Together with international colleagues, scientists from the Helmholtz Zentrum Dresden-Rossendorf (HZDR) have shown how a cobalt grid can be reliably programmed at room temperature. In addition they discovered that for every hole ("antidot") three magnetic states can be configured. The results have been published in the journal "Scientific Reports".

Physicist Dr. Rantej Bali from the HZDR, together with scientists from Singapore and Australia, designed a special grid structure in a thin layer of cobalt in...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Booth and panel discussion – The Lindau Nobel Laureate Meetings at the AAAS 2017 Annual Meeting

13.02.2017 | Event News

Complex Loading versus Hidden Reserves

10.02.2017 | Event News

International Conference on Crystal Growth in Freiburg

09.02.2017 | Event News

 
Latest News

Biocompatible 3-D tracking system has potential to improve robot-assisted surgery

17.02.2017 | Medical Engineering

Real-time MRI analysis powered by supercomputers

17.02.2017 | Medical Engineering

Antibiotic effective against drug-resistant bacteria in pediatric skin infections

17.02.2017 | Health and Medicine

VideoLinks
B2B-VideoLinks
More VideoLinks >>>